Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of genetic tests for susceptibility to common complex diseases: why, when and how?

Human genetics - 1 Feb 2010

Wright Caroline Fiona, Kroese Mark

Abstract excerpt

Recent research into the human genome has generated a wealth of scientific knowledge and increased both public and professional interest in the concept of personalised medicine. Somewhat unexpectedly, in addition to increasing our understanding about the genetic basis for numerous diseases, these new discoveries have also spawned a burgeoning new industry of 'consumer genetic testing'. In this paper, we present...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Predisposition to Disease
Share to Genetic Privacy
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Government Regulation

Share to Informed Consent

Share to Physician-Patient Relations

Share to United Kingdom

Share to United States

Source

Identifiers

PMID: 19936793
DOI: 10.1007/s00439-009-0767-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of genetic tests for susceptibility to common complex diseases: why, when and how?PMID 19936793Read ↗

The evaluation of genetic tests.Semantic proximity Read ↗

Considerations for designing a prototype genetic test for use in translational research.Semantic proximity Read ↗

The past, present, and future of direct-to-consumer genetic tests.Semantic proximity Read ↗

What ethical and legal principles should guide the genotyping of children as part of a personalised screening programme for common cancer?Semantic proximity Read ↗

The future of commercial genetic testingSemantic proximity Read ↗

'Over-the-counter' genetic testing: what does it really mean for primary care?Semantic proximity Read ↗

Ethical, legal, and social issues in genetic testing for complex genetic diseases.Semantic proximity Read ↗

Genetic testing for disease susceptibility: social, ethical and legal issues for family physicians.Semantic proximity Read ↗

Statement of the ESHG on direct-to-consumer genetic testing for health-related purposesSemantic proximity Read ↗

Predictive genetic testing in young people for adult-onset conditions: where is the empirical evidence?Semantic proximity Read ↗

Growing complexity of (expanded) carrier screening: Direct-to-consumer, physician-mediated, and clinic-based offers.Semantic proximity Read ↗

[Genetic testing of risk alleles of common diseases. Critical scrutiny of clinical applicability].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.